Report cover image

The 2023 Vaccine Market Report

Publisher Health Industry Distributors Association (HIDA)
Published Nov 01, 2023
Length 29 Pages
SKU # HD18333995

Description

The 2023 Vaccine Market Report


Market At-A-Glance
In 2023, the global vaccine market is valued at $102.9 billion and is expected to grow to $114.7 billion by 2030. Growth of the vaccine market is driven largely by the recent commercialization of the COVID-19 vaccine in the U.S. The U.S. vaccine market alone is projected to increase 47% from $23.8 billion in 2023 to $35.1 billion in 2030.

Updated COVID-19 Vaccines Hit The Market Despite Declining Demand
Following the Food and Drug Administration’s (FDA) authorization of an updated monovalent COVID-19 vaccine from Pfizer/BioNTech and Moderna in September 2023, the Centers for Disease Control and Prevention (CDC) recommended everyone aged six months and older receive the monovalent COVID-19 vaccine.

Despite the new guidance, vaccine hesitancy and fatigue persist, contributing to a decline in vaccine coverage and projected global sales of COVID-19 vaccines. An all-in-one COVID-flu vaccine created with the goals of helping combat vaccine fatigue, simplifying the U.S. annual vaccination schedule, and boosting vaccine uptake is now expected in 2025.

Growth Anticipated In The Pediatric Vaccine Market Amidst Falling Vaccination Rates
The North American pediatric vaccine market is expected to grow 47% from $15.3 billion in 2022 to more than $22.5 billion by 2027, coinciding with an increase in the number of childhood vaccines recommended by the CDC. As the market grows and the number of recommended vaccines increase, childhood vaccination coverage in the U.S. continues to fall year-after-year below key targets for herd immunity.

Innovative Vaccine Candidates Progress Through The Pipeline
Multiple pioneering vaccines are progressing through clinical trials in 2023. Among them are several candidates that utilize messenger RNA (mRNA) technology which played a pivotal role in combatting the COVID-19 pandemic. Clinical trials are underway for a needle-free measles-rubella vaccine and a plasmid DNA breast cancer vaccine, both vaccines are projected to have a significant impact on the future vaccine market.

U.S. Influenza Vaccine Market Estimated To Surpass $8 Billion By 2031
The U.S. influenza vaccine market was valued at $3.96 billion in 2022 and is projected to almost triple by 2031 to $8.35 billion. As of August 2023, an estimated 156.2 million to 170 million doses of the influenza vaccine will be manufactured for the 2023–2024 flu season, falling short of the previous season’s total by 17%. Australia’s 2023–2024 flu season, which often sets the precedent for the U.S., is projected to be one of the country’s largest flu seasons to date.

Table of Contents

29 Pages
Executive Summary
Vaccine Market Overview
Vaccine Categories And Development Platforms
Messenger RNA Vaccines Evolve To Target Infectious Disease Prevention And Cancer Treatment
Plasmid DNA Breast Cancer Vaccine Shows Promise In Early-Phase Studies
FDA Approves First Vaccine Designed To Prevent RSV Disease In Infants, Babies, And Toddlers
Routine Childhood Vaccination Rates Remain Below Key Targets
Rising Vaccine Hesitancy Is Impacting Vaccine Coverage
Combined COVID-Flu Combination Vaccine No Longer Expected In 2023
Updated Vaccines Are Authorized And Recommended For 2023–2024 COVID-19 Season
Global COVID-19 Vaccine Market Experiences Drop In Projected Sales
Pharmacies Play A Key Role In COVID-19 Vaccine Administration For Adults And Children
CDC Adds COVID-19 Vaccine To Adult And Child Immunization Schedules
Minimal Updates To Flu Vaccine Composition Ahead Of The 2023–2024 Flu Season
Influenza Activity And Market Value Rise As Manufacturing Falls
High Australian Flu Cases Precede U.S. Flu Season
Pediatric And Adolescent Vaccination Schedule Grows
HPV Vaccination Rate Among Adolescents Continues To Fall Behind Other Vaccines
Initial Study Demonstrates Efficacy And Safety Of Needle-Free Measles-Rubella Vaccine
Limited Number Of Domestic Manufacturers Contributes To Vaccine Supply Chain Disruptions
Government Programs Or Insurance Cover Most Recommended Vaccines
Appendices

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us